IHU HealthAge at CTAD 2026

Nov 16–19, 2026 Boston, MA ~1.7k attendees Website

IHU HealthAge takes part in 2 sessions at CTAD 2026 in Boston. Its role in the program is introducing the meeting, at the opening ceremony and the first keynote on new molecules in phase 2b trials.

OrganizationCTAD 2026 Attendance
IHU HealthAge
Toulouse, France
ihuhealthage.fr
Universities & institutes
Toulouse university-hospital institute for research on healthy ageing and the prevention of frailty and cognitive decline.
Session
Mon Nov 16
3:15pm–3:25pm
Welcome Ceremony and CTAD Lifetime Achievement Award in Alzheimer’s Disease Therapeutic Research
with Brigham and Women's Hospital, USC Alzheimer's Therapeutic Research Institute, Toulouse University Hospital +3 more
Talk
Mon Nov 16
3:25pm–3:50pm
New Molecules in Phase 2b – Proof of Concept and Beyond
Trial design and endpoints · with University of Nevada, Las Vegas

Explore the full CTAD 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full CTAD 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from IHU HealthAge

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction